These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 30086699)

  • 1. Functional role of CyclinD1 polymorphism (G870A) in modifying susceptibility and overall survival of North Indian lung cancer patients.
    Pandey A; Bahl C; Sharma S; Singh N; Behera D
    Tumori; 2018 Jun; 104(3):179-187. PubMed ID: 30086699
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional Role of CyclinD1 Polymorphism (G870A) in Modifying Susceptibility and Overall Survival of North Indian Lung Cancer Patients.
    Pandey A; Bahl C; Sharma S; Singh N; Behera D
    Tumori; 2017 Dec; ():tj5000707. PubMed ID: 29739297
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CCND1 G870A polymorphism with altered cyclin D1 transcripts expression is associated with the risk of glioma in a Chinese population.
    Chen X; Zhao T; Li L; Xu C; Zhang X; Tse V; Zhang T; Liu X; Lu F
    DNA Cell Biol; 2012 Jun; 31(6):1107-13. PubMed ID: 22304571
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclin D1 (G870A) polymorphism and risk of cervix cancer: a case control study in north Indian population.
    Satinder K; Chander SR; Pushpinder K; Indu G; Veena J
    Mol Cell Biochem; 2008 Aug; 315(1-2):151-7. PubMed ID: 18548202
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between
    Thakur N; Kumari S; Mehrotra R
    Biosci Rep; 2018 Dec; 38(6):. PubMed ID: 30361291
    [No Abstract]   [Full Text] [Related]  

  • 6. Cyclin D1 G870A polymorphism and the risk of hepatocellular carcinoma in a Chinese population.
    Hu Z; Zhou Z; Xiong G; Wang Y; Lai Y; Deng L; Yang J
    Tumour Biol; 2014 Jun; 35(6):5607-12. PubMed ID: 24570185
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclin D1 (CCND1) A870G gene polymorphism modulates smoking-induced lung cancer risk and response to platinum-based chemotherapy in non-small cell lung cancer (NSCLC) patients.
    Gautschi O; Hugli B; Ziegler A; Bigosch C; Bowers NL; Ratschiller D; Jermann M; Stahel RA; Heighway J; Betticher DC
    Lung Cancer; 2006 Mar; 51(3):303-11. PubMed ID: 16406195
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclin D1 G870A polymorphism and lung cancer risk: a meta-analysis.
    Liu J; Liao Q; Zhang Y; Sun S; Zhong C; Liu X
    Tumour Biol; 2012 Oct; 33(5):1467-76. PubMed ID: 22528945
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclin D1 G870A polymorphism and risk of nasopharyngeal carcinoma: a case-control study and meta-analysis.
    Liao D; Wu Y; Pu X; Chen H; Luo S; Li B; Ding C; Huang GL; He Z
    PLoS One; 2014; 9(11):e113299. PubMed ID: 25409185
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CCND1 G870A polymorphism and cervical cancer risk: a case-control study and meta-analysis.
    Ni J; Wang M; Wang M; Fu S; Zhou D; Zhang Z; Han S
    J Cancer Res Clin Oncol; 2011 Mar; 137(3):489-94. PubMed ID: 20473525
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The cyclin D1 (CCND1) G870A polymorphism and lung cancer susceptibility: a meta-analysis.
    Zhou C; An H; Hu M; Liu Q; Geng P; Xu J; Sun B; Liu C
    Tumour Biol; 2013 Dec; 34(6):3831-7. PubMed ID: 23873109
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The association between CCND1 G870A polymorphism and colorectal cancer risk: A meta-analysis.
    Xie M; Zhao F; Zou X; Jin S; Xiong S
    Medicine (Baltimore); 2017 Oct; 96(42):e8269. PubMed ID: 29049220
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potential role of CCND1 G870A genotype as a predictor for urothelial carcinoma susceptibility and muscle-invasiveness in Taiwan.
    Lin HH; Ke HL; Hsiao KH; Tsai CW; Wu WJ; Bau DT; Chang LL
    Chin J Physiol; 2011 Jun; 54(3):196-202. PubMed ID: 21789902
    [TBL] [Abstract][Full Text] [Related]  

  • 14. AA genotype of cyclin D1 G870A polymorphism increases breast cancer risk: Findings of a case-control study and meta-analysis.
    Akhter N; Alzahrani FA; Dar SA; Wahid M; Sattar RSA; Hussain S; Haque S; Ansari SA; Jawed A; Mandal RK; Almalki S; Alharbi RA; Husain SA
    J Cell Biochem; 2019 Oct; 120(10):16452-16466. PubMed ID: 31243808
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of cyclin D1 A870G polymorphism with two malignancies: acute lymphoblastic leukemia and breast cancer.
    Bedewy AM; Mostafa MH; Saad AA; El-Maghraby SM; Bedewy MM; Hilal AM; Kandil LS
    J BUON; 2013; 18(1):227-38. PubMed ID: 23613410
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A cyclin D1 (CCND1) gene polymorphism contributes to susceptibility to papillary thyroid cancer in the Turkish population.
    Aytekin T; Aytekin A; Maralcan G; Gokalp MA; Ozen D; Borazan E; Yilmaz L
    Asian Pac J Cancer Prev; 2014; 15(17):7181-5. PubMed ID: 25227811
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of cyclin D1 (CCND1) polymorphism on susceptibility to lung cancer in a North Indian population.
    Sobti RC; Kaur P; Kaur S; Singh J; Janmeja AK; Jindal SK; Kishan J; Raimondi S
    Cancer Genet Cytogenet; 2006 Oct; 170(2):108-14. PubMed ID: 17011980
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic variant of CCND1: association with HPV-mediated cervical cancer in Indian population.
    Thakur N; Hussain S; Kohaar I; Tabassum R; Nasare V; Tiwari P; Batra S; Bhambhani S; Das BC; Basir SF; Bharadwaj D; Bharadwaj M
    Biomarkers; 2009 Jun; 14(4):219-25. PubMed ID: 19489683
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclin D1 G870A polymorphism is associated with risk and clinicopathologic characteristics of bladder cancer.
    Yuan L; Gu X; Shao J; Wang M; Wang M; Zhu Q; Zhang Z
    DNA Cell Biol; 2010 Oct; 29(10):611-7. PubMed ID: 20575692
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclin D1 (CCND1) G870A gene polymorphism is an ethnicity-dependent risk factor for digestive tract cancers: a meta-analysis comprising 20,271 subjects.
    Chen B; Cao L; Yang P; Zhou Y; Wu XT
    Cancer Epidemiol; 2012 Apr; 36(2):106-15. PubMed ID: 21606015
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.